Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
INGENIUM TECHNOLOGIES CORP via STROGEN LLC
2026 · third_quarter · Q3
Advocating for FY27 defense appropriations and NDAA report language to advance development of a next-generation onboard oxygen generation system (OBOGS) currently in development under an Air Force RDT&E SBIR Phase 2 project.
Filing targets: Air Force, Dept of, Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
INGENIUM TECHNOLOGIES CORP via STROGEN LLC
2026 · first_quarter · 1A
Source: Senate LDA
Advocating for FY27 defense appropriations to advance an Air Force RDT&E project currently in SBIR Phase 2.
Filing targets: Air Force, Dept of, Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
INGENIUM TECHNOLOGIES CORP via STROGEN LLC
2026 · second_quarter · Q2
Advocating for FY27 defense appropriations to advance an Air Force RDT&E project currently in SBIR Phase 2.
Filing targets: Air Force, Dept of, Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
INGENIUM TECHNOLOGIES CORP via STROGEN LLC
2026 · first_quarter · Q1
Advocating for FY27 defense appropriations to advance an Air Force RDT&E project currently in SBIR Phase 2.
Filing targets: Air Force, Dept of, Defense, Dept of (DOD)
INGENIUM TECHNOLOGIES CORP via STROGEN LLC
2026 · first_quarter · RR
Engaging with DOW technical leadership, as well as congressional energy staff, to build understanding of Ingenium's technical capabilities and accomplishments, and to develop support for their goals to advance development of ceramic oxygen generation systems (COGSs), solid oxide electrolysis cells (SOECs), and solid oxide fuel cells (SOFCs) for military applications.